COTI — Coretag Income Statement
0.000.00%
Last trade - 00:00HealthcareMicro Cap
Annual income statement for Coretag, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2015 September 30th | 2016 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.112 | 0.125 | 0 | 0 | 0 |
| Cost of Revenue | |||||
| Gross Profit | 0.031 | 0.022 | — | — | — |
| Selling / General / Administrative Expenses | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 0.148 | 0.13 | 0.017 | 0.034 | 0.03 |
| Operating Profit | -0.036 | -0.005 | -0.017 | -0.034 | -0.03 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -0.036 | -0.005 | -0.017 | -0.034 | -0.03 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.037 | -0.005 | -0.017 | -0.034 | -0.03 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.037 | -0.005 | -0.017 | -0.034 | -0.03 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.037 | -0.005 | -0.017 | -0.034 | -0.03 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -18.4 | -2.3 | -0.577 | -0.377 | -0.335 |
| Dividends per Share |